bioengineer.org /1 day ago

Dostarlimab Achieves Complete Response in Rare SMARCA4-Deficient Metastatic Uterine Sarcoma Case

A patient with metastatic SMARCA4-deficient undifferentiated uterine sarcoma achieved a 42-month complete response following dostarlimab therapy.

Read source
bioengineer.org /1 week ago

Immunotherapy Combined With Chemotherapy Extends Survival in Advanced SMARCA4-Deficient Lung Cancer

A real-world retrospective study demonstrates that adding first-line immunotherapy to chemotherapy significantly prolongs median overall survival by 23 months in advanced SMARCA4-d...

Read source
asianscientist.com /1 month ago

This Molecular Switch Helps Triple-Negative Breast Cancers Resist Treatment

Researchers uncover how the long non-coding RNA Smyca helps triple-negative breast cancer cells repair DNA damage and survive treatment.

Read source
journals.plos.org /3 days ago

GPCR-Gαq signaling drives adaptive resistance to MEK inhibition in BRAF-mutant melanoma

by Jingyi Ke, Zi Wang, Zhengyang Guo, Guangshuo Ou, Wei Li Oncogenic BRAFV600E mutations drive constitutive MAPK signaling across various cancers; however, resistance to MEK inhib...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.